AbbVie Says Rivals’ Rinvoq Generics Infringe 34 Patents – Law360

By Hailey Konnath (November 21, 2023, 10:34 PM EST) — AbbVie has lodged 136 patent infringement claims against Sandoz and a handful of other pharmaceutical companies, accusing them of infringing dozens of AbbVie’s patents with their proposed generic versions of its blockbuster immunosuppressant Rinvoq, according to a suit filed in Delaware federal court….